La vendita allo scoperto per Ellomay Cap dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Ellomay Cap. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Ellomay Cap (AMEX:ELLO) Azioni, Report sulle vendite allo scoperto

Ellomay Capital

Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.

Ellomay Capital Ltd Ordinary Shares (Israel)

Ellomay Capital Ltd

News

ELLO

Ellomay Capital Closes Deal With Clal Insurance For 49% Stake In 198 MW Italian Solar Portfolio, Marking Key Strategic Milestone

Ellomay Reports Unit Dorad Q1 Revenue Of NIS610.6M, Operating Profit Of NIS76.9M

Asset Sales

Ellomay Capital Announced That It Entered Into An Investment Agreement With Clal Insurance Ltd., And Several Of Its Affiliates, For An Aggregate Investment By Clal Of Approximately €52M

Earnings

Ellomay Capital Q4 Revenues $9.033M

Ellomay Capital Q3 EPS $0.52 Up YoY, Sales $13.8M Down YoY

Nehama served on the Board of Directors and as the Company's Chairman of the Board since March 2008 and is a controlling shareholder of the Company.
Sheizaf will serve as a director until the Company's 2025 annual general meeting, at which he can be nominated for reappointment to the Company's Board of Directors.

Management

Ellomay Capital Says Chairman Shlomo Nehama Has Decided To Resign From Board; Ben Sheizaf Named As Board Member And Chairman

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.03 per share. This is a 75 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $12.07 million in sales this quarter. This is a 17.53 percent decrease over sales of $14.64 million the same period last year.

Ellomay Capital Q2 EPS $0.03 Down From $0.12 YoY, Sales $12.07M Down From $14.64M YoY

Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today announced a key achievement in its U.S. strategic growth plan. The Company has successfully entered into an agreement for the sale and transfer of Investment Tax Credits (ITCs) linked to its Fairfield (13.4 MW), Malakoff (13.92 MW), Mexia (11.1 MW), and Talco (10.5 MW) solar projects, all located in the State of Texas, USA. The agreement was executed with a reputable financial institution, with vast experience in executing tax credit transactions.
Through this transaction, the Company expects to receive approximately $19 million from the sale of Investment Tax Credits, representing approximately 32% of the expected total portfolio costs. The sale is facilitated under the Inflation Reduction Act's new transferability provisions, allowing Ellomay to retain 100% of the operating profits from these projects. Funds from the sale of the ITCs generated from a project will be disbursed after such project is placed in service and meets the applicable requirements. The Company expects the Fairfield and Malakoff projects to be placed in service by the end of Q4 2024, and the Mexia and Talco projects to be placed in service by the end of Q2 2025. The agreement includes customary indemnification obligations (for damages not covered by tax insurance policy), including in connection with certain continued eligibility requirements and scope of the ITCs, for which the Company provided a guarantee to the purchaser of the ITCs.

Ellomay Capital Announces An Agreement For The Sale Of Investment Tax Credits From 4 Texas Solar Projects, Expecting To Receive About $19M, Representing 32% Of The Total Portfolio Costs, Under Provisions Allowing The Company To Retain All Operating Profits, With Project Completions Anticipated By Mid-2025

Ellomay  Reports Results Of Dorad Energy: Revenues For Three Months Ended June 30 Totals NIS659M, Operating Profit Totals NIS87.5M

Ellomay Capital Q1 EPS $(0.02) Down From $0.29 YoY, Sales $8.91M Down From $13.08M YoY

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly losses of $(0.56) per share. This is a 300 percent decrease over earnings of $0.28 per share from the same period last year. The company reported $9.32 million in sales this quarter. This is a 5.71 percent increase over sales of $8.81 million the same period last year.

Ellomay Capital Q4 EPS $(0.56) Down From $0.28 YoY, Sales $9.32M Up From $8.81M YoY

Ellomay Capital Ltd.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#NYSE">ELLO</a>) (TASE: ELLO) ("Ellomay" or the "Company"),&nbsp;a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel,&nbsp;today announced that it executed an agreement (the "Agreement") to sell its holdings in the 9 MW solar facility located in Talmei Yosef, Israel (the "Talmei Yosef Facility").
The Agreement provides for the sale of the Company's holdings in the Talmei Yosef Facility to Greenlight Fund Limited Partnership and Doral Group Renewable Energy Resources Ltd., in equal parts, in consideration for NIS 44.75 million (approximately $12.2 million), with an additional potential payment of up to NIS 4 million in the event the Talmei Yosef Facility will produce more than 18 million Kwh during 2024. The Agreement provides for a cutoff date of June 30, 2023 and the Company will be entitled to all revenues of the Talmei Yosef Facility up to such date, net of expenses for the period.
The Agreement includes customary representations and indemnification undertakings in connection with breaches of representations, which, other than with respect to customary exceptions, are subject to a cap of NIS 9 million and limited to a period of 18 months from the closing date.
The consummation of the sale is subject to various customary conditions to closing, including receipt of regulatory approvals and the consent of the financing entity of the Talmei Yosef Facility. All conditions to closing are required to be fulfilled within a period of 90 days from execution of the Agreement, which can be extended to up to 150 days under certain circumstances.
The Talmei Yosef Facility is located in southern Israel. One of the conditions to closing is the end of the war in southern Israel and that the Talmei Yosef Facility will be physically accessible. In addition, the Agreement provides that in the event that due to the current war and hostilities in Israel the facility will be damaged or its output will decrease, the buyers will have the right not to consummate the acquisition of the facility.
Following consummation of the sale, the Company will maintain the rights to the two projects under development located in the vicinity of the Talmei Yosef Facility: (i) a solar facility intended for 10 solar MW and 22 MW / hour batteries, and (ii) a battery storage facility intended for approximately 400 MW / hour.
As noted above, the consummation of the transactions contemplated by the Agreement is subject to the fulfilment of the conditions to closing, that are mostly not within the control of the Company or the buyers. There can be no assurance as to whether or when the conditions to closing will be satisfied and as to the impact of the war and hostilities in Israel on the ability to consummate the sale and on the final purchase price.

Ellomay Capital Enters Into An Agreement To Sell The Talmei Yosef Solar Facility To Greenlight Fund Limited Partnership And Doral Group Renewable Energy Resources Ltd., In Equal Parts, In Consideration For Approximately $12.2M

Ellomay Capital Says Does Not Expect Material Impact On The Timeline For Pumped Storage Project Construction In Israel

<a href="https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm" title="https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm">https://www.sec.gov/Archives/edgar/data/946394/000117891323003306/zk2330368.htm</a>

Ellomay Capital Says Construction Works In The Site Of Its Pumped Storage Project In The Manara Cliff, Israel Were Halted - Filing

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.12 per share. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $14.64 million in sales this quarter. This is a 21.22 percent decrease over sales of $18.58 million the same period last year.

Ellomay Capital Q2 EPS $0.12 Down From $0.14 YoY, Sales $14.64M Down From $18.58M YoY

Ellomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.29 per share. This is a 211.54 percent increase over losses of $(0.26) per share from the same period last year. The company reported $13.08 million in sales this quarter. This is a 0.27 percent increase over sales of $13.05 million the same period last year.

CORRECTION: Ellomay Capital Q1 EPS $0.29 Up From $(0.26) YoY, Sales $13.08M Up From $13.05M YoY

Ellomay Capital (AMEX:ELLO) reported quarterly earnings of $0.27 per share. This is a 203.85 percent increase over losses of $(0.26) per share from the same period last year. The company reported $12.03 million in salesEllomay Capital (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#AMEX">ELLO</a>) reported quarterly earnings of $0.27 per share. This is a 203.85 percent increase over losses of $(0.26) per share from the same period last year. The company reported $12.03 million in sales this quarter. This is a 7.82 percent decrease over sales of $13.05 million the same period last year.

Ellomay Capital Q1 EPS $0.29 Up From $(0.26) YoY, Sales $13.08M Up From $13.05M YoY

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 100 points on Wednesday.
The Dow traded down 0.34% to 32,929.04 while the NASDAQ fell 0.30% to 12,978.20. The S&amp;P 500, also fell, dropping, 0.39% to 4,189.27.
Check This Out: <a href="https://www.benzinga.com/news/23/05/32646285/top-5-tech-and-telecom-stocks-that-are-flying-and-may-collapse"> Top 5 Tech And Telecom Stocks That Are Flying - And May Collapse</a>
&nbsp; 
<h3>Leading and Lagging Sectors</h3>
<ul>
<li>Utilities shares rose by 0.7% on Wednesday. Meanwhile, top gainers in the <a href='https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/'>sector</a> included Ellomay Capital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ello#NYSE">ELLO</a>), up 8%, and Star Group, L.P. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sgu#NYSE">SGU</a>), up 4%.</li>
<li>In trading on Wednesday, energy shares dipped 1.8%.</li>
</ul>

&nbsp; 
<h3>Top Headline</h3>

Shares of Donaldson Co Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dci#NYSE">DCI</a>) dropped over 7% on Wednesday after the company reported third-quarter financial results and updated guidance.
Donaldson reported a sales increase of 2.6% Y/Y to $875.7 million beating the consensus of $868.4 million. EPS stood at 76 cents, up from 67 cents a year ago, exceeding the consensus of $0.74.
The company now expects FY23 adjusted EPS to be $3.00-$3.06 (vs $2.99-$3.07 previously) compared to the consensus of $3.04.
&nbsp; 
<h3>Equities Trading UP</h3>
<ul>
<li>Aridis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ards#NASDAQ">ARDS</a>) shares shot up 116% to $0.3991 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of AR-301 and the clinical study design.</li>
<li>Shares of Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) got a boost, shooting 32% to $1.7401 after the company reported pre-clinical data of its MT-601 multiTAA-specific T cell product candidate MT-601 in lymphoma cells.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) shares were also up, gaining 17% to $0.1567 after the company announced it will present fasedienol safety and exploratory efficacy data from its Phase 3 open-label social anxiety disorder study at the ASCP 2023 Annual Meeting.</li>
</ul>

&nbsp; 
<h3>Equities Trading DOWN</h3>
<ul>
<li>Advance Auto Parts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aap#NYSE">AAP</a>) shares dropped 34% to $73.70 after the company reported worse-than-expected first-quarter financial results and cut FY23 guidance below estimates.</li>
<li>Shares of Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) were down 32% to $0.2298. Panbela announced a 1-for-30 reverse stock split effective June 1, 2023.</li>
<li>QualTek Services Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtek#NASDAQ">QTEK</a>) was down, falling 44% to $0.0842 after the company received Nasdaq delisting notice.</li>
</ul>

Also Check This Out: <a href="https://www.benzinga.com/news/23/05/32647354/amd-micron-and-2-other-stocks-insiders-are-selling"> AMD, Micron And 2 Other Stocks Insiders Are Selling</a>
&nbsp; 
<h3>Commodities</h3>

In commodity news, oil traded down 2% to $68.10 while gold traded up 0.3% at $1,983.50.
Silver traded up 1.5% to $23.59 on Wednesday while copper fell 0.7% to $3.6370.
&nbsp; 
<h3>Euro zone</h3>

European shares were lower today. The eurozone&rsquo;s STOXX 600 fell 1.07%, London&rsquo;s FTSE 100 fell 1.01% while Spain&rsquo;s IBEX 35 Index fell 1.28% The German DAX slipped 1.54% French CAC 40 fell 1.54% and Italy&rsquo;s FTSE MIB Index fell 1.97%.
The annual inflation rate in Italy declined to 7.6% in May from 8.2% in the prior month, while GDP grew by 0.6% quarter-on-quarter during the three months to March 2023. Spain reported a current account surplus of &euro;5575 million in March, recording the highest surplus since July 2016.
The unemployment rate in Germany was steady at 5.6% during May. The French economy expanded 0.2% on quarter in the first quarter, while producer prices fell 5.1% month-over-month in April. The consumer price inflation in France dropped to 5.1 % year-over-year for May.
&nbsp; 
<h3>Asia Pacific Markets</h3>

Asian markets closed lower on Wednesday, with Japan&rsquo;s Nikkei 225 dropping 1.41%, Hong Kong&rsquo;s Hang Seng Index declining 1.94% and China&rsquo;s Shanghai Composite Index falling 0.61%. India&rsquo;s S&amp;P BSE Sensex fell 0.6%.
Japan&#39;s housing starts fell by 11.9% year-over-year in April versus aa 3.2% decline in the previous month, while consumer confidence index in Japan rose to 36 in May from 35.4 a month ago. Retail sales in Japan rose by 5% year-over-year in April, while industrial production fell by 0.4 % month-over-month during April.
The official NBS non-manufacturing PMI for China fell to 54.5 in May from 56.4 in the previous month, while official NBS manufacturing PMI declined to a five-month low level of 48.8 in May.
&nbsp; 
<h3>Economics</h3>
<ul>
<li>The Chicago PMI declined to 40.4 points in May versus 48.6 in April.</li>
<li>The number of job vacancies in the U.S. rose by 358 thousand to 10.1 million in April.</li>
</ul>

Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/05/32648620/bitcoin-drops-but-remains-above-this-key-level-optimism-conflux-among-top-losers"> Bitcoin Drops But Remains Above This Key Level; Optimism, Conflux Among Top Losers</a>
&nbsp; 
<h3>COVID-19 Update</h3>

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,107,490 cases with around 1,165,310 deaths. India confirmed a total of at least 44,990,580 cases and 531,870 deaths, while France reported over 40,081,380 COVID-19 cases with 167,310 deaths. In total, there were at least 689,549,940 cases of COVID-19 worldwide with more than 6,884,630 deaths.
&nbsp;

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

ARDS

MRKR

PBLA

QTEK

VTGN

Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results

Ellomay Capital 2022 Revenues €53.4M

Ellomay Capital Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELLO#NYSE">ELLO</a>) (TASE: ELLO)&nbsp;(&quot;Ellomay&quot; or the &quot;Company&quot;), a renewable energy and power generator and developer of renewable energy and power projects in&nbsp;Europe&nbsp;and&nbsp;Israel, today announced its entry into a Joint Development Agreement (the &quot;JDA&quot;) for the development of solar photovoltaic projects in the&nbsp;State of Texas.
The JDA was executed with a project development company experienced in the development of energy projects, site acquisition, capital markets and commercial management. The JDA provides for the initial development, design, construction and finance of two solar PV projects with aggregate projected DC capacity of 23 MW (the &quot;First Projects&quot;). The First Projects are in advanced stages of development and the estimated capital costs of the First Projects are in the range of&nbsp;$25-$27 million. The Company&#39;s share of the capital costs of the First Projects is estimated at approximately&nbsp;$18-$20 million&nbsp;and the balance is intended to be provided by tax equity sources with whom the Company is currently in discussions.&nbsp;The sites for the First Projects will be leased under long-term leases from special purpose companies (Landcos) controlled by the development team. &nbsp;One of the First Projects, with a DC capacity of approximately 13 MW, is expected to achieve Ready to Build status within six months. The JDA also provides for the development of three additional solar PV projects up to Ready to Build status with aggregate DC capacity of approximately 30 MW.
The projects to be developed under the JDA will be subject to the ERCOT Distributed Generation (&quot;DG&quot;) Scheme for projects of up to 10 MW AC capacity and the applicable electricity market is the &quot;ERCOT North&quot; zone market. Under the DG Scheme, ERCOT (the electricity regulator of the&nbsp;State of Texas), allows owners of generation assets to sell electricity to Qualified Service Entities (QSE&#39;s) at market rates under Real Time or Day Ahead prices at the local nodes where the projects are located and/or to designated &quot;Behind the Meter&quot; clients under Power Purchase Agreements.

Ellomay Capital Marks US Solar Photovoltaic Market Foray

Press Releases

Ellomay Capital Announces an Extraordinary General Meeting of Shareholders

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2024

Ellomay Capital Announces Results of Extraordinary General Meeting of Shareholders

Ellomay Capital Announces Execution of Project Finance Agreements for its 198 MW Solar Portfolio in Italy

Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024

Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2024

Ellomay Capital Ltd. Announces the Execution of an Agreement to sell 49% of its Italian Solar Portfolio of 198 MW to Clal Insurance, a Leading Israeli Institutional Investor

Comments

Ellomay Cap

Vendite allo scoperto

Ellomay Cap (AMEX:ELLO) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO